Datasets (28,470)

RNA-Seq analysis of primary AML specimens exposed to AhR modulating agents

Generating STAT3/5 resistant human breast cancer cell lines (MDA-MB-231 & T47D) using chronic treatment with SH-4-54

Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs

HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy

Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state

Glutamine Deficiency Occurs in Regions of Solid Tumours and Promotes Dedifferentiation through Inhibition of Histone Demethylation

DSBCapture: in situ capture and direct sequencing of dsDNA breaks

TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling

Homo sapiens isolate:H9 HESCs (WA09) Transcriptome or Gene expression

RNA-seq of naive and primed ES cells

High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML

Transcriptome analysis of SF3B1-mutation induced changes in K562 cells

Interleukin-17 Promotes Neutrophil-Mediated Immunity by Activating Microvascular Pericytes and Not Endothelium

Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells

Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells